YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
From a valuation perspective, Utah Medical Products, Inc. UTMD stock looks expensive. UTMD is currently trading at a trailing 12-month enterprise value/sales (EV/sales) of 4.05X, above the industry average of 2.68X. UTMD also trades at a h…
[Oracle Corporation Glass Logo] FinkAvenue Insider transactions were registered at relatively few but major firms this week, including Oracle (ORCL [https://seekingalpha.com/symbol/ORCL]), Alibaba (BABA [https://seekingalpha.com/symbol/BAB…
Seasoned beverage and CPG executive brings decades of leadership experience across finance, operations, strategy, and corporate transformation LA CROSSE, Wis., September 25, 2026--(BUSINESS WIRE)--City Brewing & Beverage ("City Brewing" or…
Canopy Services is leveraging ServiceTitan Inc.'s (NASDAQ:TTAN) end-to-end roofing capabilities for its growing portfolico of roofing brands. The residential roofing platform is standardizing its core functions through ServiceTitan's propr…
In the latest close session, Canopy Growth Corporation (CGC) was down 2.34% at $0.94. The stock's performance was behind the S&P 500's daily loss of 0.76%. Elsewhere, the Dow lost 0.68%, while the tech-heavy Nasdaq lost 1.13%. Shares of th…
Canopy Growth (NASDAQ: CGC) did a reverse stock split on Dec. 15, 2023. After that split, the stock fell by nearly 50% before there was a brief marijuana stock rally. Today, the shares are down by roughly 80% from their pre-reverse-split l…
McDonald's, Chick-fil-A, and Taco Bell lead the list of top tech experiences for the second year in a row ALPHARETTA, Ga., September 23, 2026--(BUSINESS WIRE)--Canopy, the trusted provider of AI supervision for unsupervised devices, today…
Marijuana plants ©Adobe Stock Images Canopy Growth Corporation (NASDAQ:CGC) has announced an agreement with GROW Group U.K. Ltd. to supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom. The prod…
Canopy will use Oracle technologies to win and drive customer success together with Oracle. ALPHARETTA, Ga., September 22, 2026--(BUSINESS WIRE)--Canopy, a leading provider of AI supervision for unsupervised devices, today announced it has…
[Partnership word near puzzle pieces. Teamwork concept. Strategic cooperation. Reliable partner. 3d render] Canopy Growth Corporation (CGC [https://seekingalpha.com/symbol/CGC]) announced an agreement to supply [https://seekingalpha.com/pr…
This week, insider transactions were seen across firms like CrowdStrike (CRWD [https://seekingalpha.com/symbol/CRWD]) and Uber (UBER [https://seekingalpha.com/symbol/UBER]). The following deals occurred between September 14 and September 1…
Canopy Growth Corporation (CGC) closed at $0.94 in the latest trading session, marking a +2.57% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 1.14%. Elsewhere, the Dow saw an upswing of 0.61%, wh…
Canopy Growth Corporation (CGC) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this company have return…
ServiceTitan Leading Residential Roofing Platform Unifies Sales, Production and Customer Management Across its Family of Leading Roofing Brands LOS ANGELES, Sept. 15, 2026 (GLOBE NEWSWIRE) -- ServiceTitan (Nasdaq: TTAN), the software platf…
Canopy Growth Corporation (CGC) closed at $0.94 in the latest trading session, marking a +1.15% move from the prior day. The stock outpaced the S&P 500's daily loss of 0.48%. On the other hand, the Dow registered a loss of 0.29%, and the t…
As seen in Canopy Growth's (NASDAQ: CGC) latest quarterly earnings release, a turnaround remains in motion. In its fiscal 2027's first quarter, ended June 30, 2026, the Canada-based cannabis company reported net revenue of $81.2 million CA…
Canopy Growth (NASDAQ: CGC) grew its revenue by 13% year over year to $58.9 million in its fiscal 2027 first quarter, but the stock barely reacted because investors have seen plenty of nascent Canopy turnarounds that never quite materializ…
Canopy Growth (NASDAQ: CGC) started trading publicly in Canada in 2014 via a reverse merger (then known as Tweed). It eventually got a listing in the United States in 2018, becoming one of the first U.S.-traded marijuana companies. The sto…
Tilray Brands (NASDAQ: TLRY) and Canopy Growth (NASDAQ: CGC) are two of the largest cannabis retailers in Canada. Neither stock has fared well this year, with Canopy's shares down by more than 12% and Tilray's by more than 49%. Cannabis st…
Quick Read Tilray's 6% gain leaves TLRY down 48% YTD, while peers Canopy Growth and Aurora Cannabis are each off just 13%. MSOS trades down just 4% YTD, exposing Tilray's 48% decline as a company-specific failure rather than a broader sect…
Canopy Growth (NASDAQ: CGC) has spent the better part of the past five years destroying shareholder value. The stock is down more than 99% from its all-time high. The company has burned through billions of dollars, diluted shareholders rep…
Key Takeaways; Cannabis Sector Canopy Growth Posted 13% Revenue Growth as Losses Narrowed Sharply in Q1 FY2027 Aurora Cannabis Narrowed Q1 Loss as International Medical Cannabis Growth Gained Ground Cronos Group Reported Record Q2 Revenue…
Download the Complete Report Here Aurora Cannabis Inc. (ACB) International Medical Growth Absorbs Much of Canadian Pricing Reset; Safari and Germany Momentum Strengthen the Medium-Term Growth Outlook. Attractively Valued. Key Takeaways: In…
Canopy Growth (NASDAQ: CGC) is one of a handful of marijuana stocks that were all the rage early on as investors thought pot would be a huge growth market. Pot demand has grown dramatically, but marijuana stocks didn't live up to the early…
Key Points The United States is slowly moving toward the legalization of marijuana. The next big step is the rescheduling of the drug at the federal level, which won't make it legal, just less illegal. Canopy Growth's business won't be dra…
Key Points Interested in Canopy Growth Corporation? Here are five stocks we like better. Canopy Growth's fiscal Q1 2027 revenue rose 13% to C$81.2 million, with year-over-year growth across its cannabis and Storz & Bickel businesses. Adjus…
ResMed (RMD) came out with quarterly earnings of $2.95 per share, beating the Zacks Consensus Estimate of $2.9 per share. This compares to earnings of $2.55 per share a year ago. These figures are adjusted for non-recurring items. This qua…
Insulet (PODD) came out with quarterly earnings of $1.66 per share, beating the Zacks Consensus Estimate of $1.44 per share. This compares to earnings of $1.17 per share a year ago. These figures are adjusted for non-recurring items. This…
Key Points The DEA's decision on rescheduling cannabis is the next key catalyst for Canopy Growth. A decision could be forthcoming following recent government hearings. Given past experience, waiting for the market to digest the news may b…
For Canopy Growth (NASDAQ: CGC), as with most cannabis stocks, the next key catalyst has nothing to do with the industry or the economy. Instead, what will likely cause marijuana stocks to surge or sink from here has to do with an upcoming…
Canopy Growth Corporation (CGC) closed at $0.91 in the latest trading session, marking a -2.67% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.14% for the day. Meanwhile, the Dow lost 0.01%, and…
At the end of last year, the cannabis industry was rocked by a significant change in the laws covering the drug. This, however, wasn't as momentous as it first seemed. Let's shine a grow light on how it will affect -- or not -- three promi…
Few stocks have destroyed as much shareholder value as Canopy Growth (NASDAQ: CGC). Since its 2018 peak, shares of the cannabis producer have lost more than 99% of its value as the industry struggled with oversupply, regulatory delays, and…
Key Points A reverse stock split may be necessary for Canopy Growth to keep its stock price above $1 and be in compliance with Nasdaq listing requirements. Canopy Growth last did a reverse split in December 2023. Its poor financial results…
Canopy Growth (NASDAQ: CGC) may have surged during the spring's rescheduling rally for marijuana stocks, but since then, this popular cannabis legalization play has coughed back these gains, falling back below $1 per share as I write this.…
Key Points While the analyst backs his bull case with estimates and facts, it's hard to envision triple-digit percentage gains for this Canada-based cannabis stock. Even if you're bullish on the U.S. legalization trend, it's smarter to sti…